Grant Distribution
Since our establishment, more than RM 15 million worth of research grants has been awarded by various agencies to our research fellows.
Year |
Research Project |
2007 | 173,400 |
2008 | 562,075 |
2009 | 219,000 |
2010 | 345,900 |
2011 | 9,783,409 |
2012 | 1,882,792 |
2013 | 1,079,983 |
2014 | 1,350,000 |
Total | 15,396,559 |
NATIONAL LEVEL RESEARCH FUNDING (MOSTI/FRGS & Others) (2007 – 2012)
No. |
Research Project |
1. |
Metagenomics and metabolomics analysis of human gut microbiota: evaluation of the predisposing mechanisms and probiotic effects on obesity. Project Head – Teh Lay Kek, UiTM,FRGS, MOHE (2012-2014) |
2. |
Exploring the metabolic regulatory networks of virulence and resistence behaviour of pathogenic klebsiella pneumoniae and proteus mirabilis using whole genome sequencing, proteomics and metabolomics approaches. Project Head – Mohd Zaki Salleh, UiTM, ERGS, MOHE (2012-2014) |
3. |
Evolutionary Genomics and Anthropological Approaches on the Endangered Malaysian Aborigine Populations: Towards Ensuring their Sustainability. Program Head – Mohd Zaki Salleh, UiTM, LGRS, MOHE (2011-2016) |
4. |
Top Down LRGS Program Tropical Tuberculosis: Delineating Host-Environment-Pathogen Interactions. Program Head – Norazmi Mohd Nor, USM LRGS, MOHE (2011-2014) |
5. |
Human thromboxane synthase gene (CYP5A1) and glycoprotein IIb/IIIa complex: Implication in the mechanism of aspirin resistance. Project Head – Teh Lay Kek, UiTM, FRGS, MOHE (2010-2011) |
6. |
A whole genome analysis of the adaptive power of S. aureus to antibiotics: emergence of methicillin-resistant S. aureus (MRSA) Project Head – Mohd Zaki Salleh, UiTM, FRGS, MOHE (2010-2011) |
7. |
Unraveling the molecular mechanism attributing to the ultra-rapid metabolism of CYP2C9.Project Head – Fazleen Haslinda Mohd Hatta, UiTM, FRGS, MOHE (2010-2011) |
8. |
Tacrolimus pharmacogenetics: the influence of genetic polymorphism of CYP3A5, MDR1 and Pregnane X receptor (PXR) in transplant patients. eScience MOSTI, Project Head – Mohd Zaki Salleh (2008-2010) |
9. |
Genetic polymorphism of drug metabolizing enzymes and estrogen receptors in pharmacogenetics of tamoxifen: implication for optimization of breast cancer treatment. Project Head – Teh Lay Kek, eScience MOSTI, (2008-2010) |
10. |
The Relevance of Genetic Profile in Optimization Drug Therapy for Thiopurine and 5- Fluorouracils. Project Head – Teh Lay Kek, UiTM, FRGS, MOHE (2007-2009) |